About Etcembly

Founded in 2020 in Oxfordshire, UK, Etcembly is redefining biologics drug development by fusing human ingenuity with artificial intelligence. Having already worked on developing more than 20 FDA-approved drugs, the founding team had seen the same obstacles repeatedly. Brilliant lab scientists were constrained by the lack of intuitive computational tools, leaving vast scientific potential untapped and innovation slowed to a crawl. Etcembly was built to change that.